Qiagen NV (QGEN)
42.78
+0.45
(+1.06%)
USD |
NYSE |
Nov 22, 16:00
42.79
+0.01
(+0.02%)
After-Hours: 20:00
Qiagen Profit Margin (Quarterly): 19.54% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 19.54% |
| June 30, 2024 | -36.96% |
| March 31, 2024 | 17.58% |
| December 31, 2023 | 19.18% |
| September 30, 2023 | 16.35% |
| June 30, 2023 | 16.33% |
| March 31, 2023 | 17.52% |
| December 31, 2022 | 17.84% |
| September 30, 2022 | 16.49% |
| June 30, 2022 | 18.75% |
| March 31, 2022 | 24.72% |
| December 31, 2021 | 22.18% |
| September 30, 2021 | 24.90% |
| June 30, 2021 | 21.34% |
| March 31, 2021 | 22.78% |
| December 31, 2020 | 37.23% |
| September 30, 2020 | 3.50% |
| June 30, 2020 | 20.25% |
| March 31, 2020 | 10.70% |
| December 31, 2019 | 10.87% |
| September 30, 2019 | -41.98% |
| June 30, 2019 | 11.72% |
| March 31, 2019 | 8.47% |
| December 31, 2018 | 15.12% |
| September 30, 2018 | 15.96% |
| Date | Value |
|---|---|
| June 30, 2018 | 9.76% |
| March 31, 2018 | 9.40% |
| December 31, 2017 | -10.00% |
| September 30, 2017 | 13.32% |
| June 30, 2017 | 4.00% |
| March 31, 2017 | 5.74% |
| December 31, 2016 | 2.35% |
| September 30, 2016 | 10.28% |
| June 30, 2016 | 6.36% |
| March 31, 2016 | 5.27% |
| December 31, 2015 | 14.81% |
| September 30, 2015 | 10.79% |
| June 30, 2015 | 7.86% |
| March 31, 2015 | 6.53% |
| December 31, 2014 | 7.10% |
| September 30, 2014 | 10.31% |
| June 30, 2014 | 9.92% |
| March 31, 2014 | 7.34% |
| December 31, 2013 | 16.66% |
| September 30, 2013 | 12.64% |
| June 30, 2013 | -16.42% |
| March 31, 2013 | 6.58% |
| December 31, 2012 | 11.09% |
| September 30, 2012 | 9.58% |
| June 30, 2012 | 10.85% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-36.96%
Minimum
Jun 2024
37.23%
Maximum
Dec 2020
16.05%
Average
18.30%
Median
Profit Margin (Quarterly) Benchmarks
| LENZ Therapeutics Inc | -- |
| Oruka Therapeutics Inc | -- |
| Boston Scientific Corp | 11.12% |
| Merus NV | -848.7% |
| uniQure NV | -1.94K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.58% |
| Return on Assets | 1.57% |
| Return on Invested Capital | 1.80% |
| Gross Profit Margin (Quarterly) | 61.43% |
| Operating Margin (Quarterly) | 24.08% |
| Return on Net Operating Assets | 2.10% |